drugset

drugset / Trial / NCT00545844

Singulair(R) In Asthma And Allergic Rhinitis (0476-383)

NCT00545844 ↗

Phase 4 Completed 313 enrolled Organon and Co

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Effectiveness of adding montelukast to inhaled corticosteroids in adult subjects with both uncontrolled asthma and allergic rhinitis.

Timeline

Start: 2007-04-01
Primary completion: 2008-01-01
Completion: 2008-01-01

Publications

Keith PK, Koch C, Djandji M, Bouchard J, Psaradellis E, Sampalis JS, Schellenberg RR, McIvor RA. Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J. 2009 May-Jun;16 Suppl A(Suppl A):17A-31A. doi: 10.1155/2009/145071.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Montelukast	Other / unclassified	10 mg	—

Indications